Goldman Sachs’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,062,350
| Closed | -$161M | – | 5722 |
|
|
2022
Q3 | $161M | Buy |
1,062,350
+343,671
| +48% | +$52M | 0.04% | 422 |
|
|
2022
Q2 | $105M | Buy |
718,679
+345,694
| +93% | +$50.4M | 0.03% | 577 |
|
|
2022
Q1 | $44.2M | Buy |
372,985
+134,599
| +56% | +$16M | 0.01% | 1165 |
|
|
2021
Q4 | $32.9M | Buy |
238,386
+111,844
| +88% | +$15.4M | 0.01% | 1399 |
|
|
2021
Q3 | $17.6M | Sell |
126,542
-303,925
| -71% | -$42.2M | ﹤0.01% | 1838 |
|
|
2021
Q2 | $41.8M | Buy |
430,467
+126,951
| +42% | +$12.3M | 0.01% | 1211 |
|
|
2021
Q1 | $20.7M | Sell |
303,516
-215,362
| -42% | -$14.7M | 0.01% | 1656 |
|
|
2020
Q4 | $44.5M | Buy |
518,878
+52,229
| +11% | +$4.48M | 0.01% | 1031 |
|
|
2020
Q3 | $30.3M | Buy |
466,649
+40,932
| +10% | +$2.66M | 0.01% | 1206 |
|
|
2020
Q2 | $31.1M | Buy |
425,717
+15,327
| +4% | +$1.12M | 0.01% | 1176 |
|
|
2020
Q1 | $14M | Sell |
410,390
-167,920
| -29% | -$5.71M | ﹤0.01% | 1565 |
|
|
2019
Q4 | $31.5M | Buy |
578,310
+269,776
| +87% | +$14.7M | 0.01% | 1312 |
|
|
2019
Q3 | $12.9M | Buy |
308,534
+69,567
| +29% | +$2.9M | ﹤0.01% | 1803 |
|
|
2019
Q2 | $10.5M | Sell |
238,967
-25,209
| -10% | -$1.1M | ﹤0.01% | 1929 |
|
|
2019
Q1 | $13.6M | Buy |
264,176
+48,549
| +23% | +$2.5M | ﹤0.01% | 1844 |
|
|
2018
Q4 | $7.97M | Buy |
215,627
+163,893
| +317% | +$6.06M | ﹤0.01% | 2040 |
|
|
2018
Q3 | $1.94M | Buy |
51,734
+2,558
| +5% | +$96.1K | ﹤0.01% | 2900 |
|
|
2018
Q2 | $1.94M | Buy |
49,176
+13,076
| +36% | +$517K | ﹤0.01% | 2895 |
|
|
2018
Q1 | $930K | Buy |
36,100
+6,378
| +21% | +$164K | ﹤0.01% | 3228 |
|
|
2017
Q4 | $802K | Buy |
+29,722
| New | +$802K | ﹤0.01% | 3243 |
|